| | | 65673 | | 17.09.2015 | | Novartis Pharma Schweiz AG | | | | | | | | | | | | | 02.07.20. | | | | 02.07.20. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Entresto 50 mg | Filmtabletten | Coated tablets (Sacubitrilum 24.3 mg, Valsartan 25.7 mg) | C09DX04 | CI | | 02 | Entresto 100 mg | Filmtabletten | Coated tablets (Sacubitrilum 48.6 mg, Valsartan 51.4 mg) | C09DX04 | CI | | 03 | Entresto 200 mg | Filmtabletten | Coated tablets (Sacubitrilum 97.2 mg, Valsartan 102.8 mg) | C09DX04 | CI |
|
|
